Tony Butler
Stock Analyst at Rodman & Renshaw
(0.99)
# 3,647
Out of 4,761 analysts
106
Total ratings
32.35%
Success rate
-13.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $7.11 | +251.62% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $3.33 | +230.33% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $3.46 | +420.23% | 4 | Sep 26, 2024 | |
| MURA Mural Oncology | Initiates: Buy | $15 | $4.05 | +270.37% | 1 | Jun 28, 2024 | |
| LPTX Leap Therapeutics | Initiates: Buy | $8 | $0.48 | +1,565.97% | 1 | Jun 28, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $0.73 | +2,091.48% | 5 | Aug 10, 2023 | |
| ADAP Adaptimmune Therapeutics | Reiterates: Buy | $10 | $0.56 | +1,687.31% | 8 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.42 | +604.23% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $47.91 | +56.54% | 8 | Aug 8, 2023 | |
| MRUS Merus | Reiterates: Buy | $35 | $47.37 | -26.11% | 7 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $60 | $2.15 | +2,690.70% | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $2.10 | +519.05% | 6 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $11.66 | +328.82% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.17 | +591.24% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.41 | +6,025.95% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.28 | +1,071.88% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.40 | +2,425.25% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $2.35 | +623.40% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $3.32 | +4,900.00% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $13.98 | +329.18% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.27 | +2,846.59% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.55 | +985.97% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $0.39 | +2,207.69% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $2.64 | -24.24% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $0.13 | +13,328.12% | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.96 | +278.79% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $1.57 | +536.94% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $2.92 | +413.70% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $12.17 | +803.86% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.72 | +10,966.54% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $7.11
Upside: +251.62%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $3.33
Upside: +230.33%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $3.46
Upside: +420.23%
Mural Oncology
Jun 28, 2024
Initiates: Buy
Price Target: $15
Current: $4.05
Upside: +270.37%
Leap Therapeutics
Jun 28, 2024
Initiates: Buy
Price Target: $8
Current: $0.48
Upside: +1,565.97%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $0.73
Upside: +2,091.48%
Adaptimmune Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $10
Current: $0.56
Upside: +1,687.31%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.42
Upside: +604.23%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $47.91
Upside: +56.54%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $47.37
Upside: -26.11%
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $2.15
Upside: +2,690.70%
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $2.10
Upside: +519.05%
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $11.66
Upside: +328.82%
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $2.17
Upside: +591.24%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.41
Upside: +6,025.95%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $1.28
Upside: +1,071.88%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $0.40
Upside: +2,425.25%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $2.35
Upside: +623.40%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $3.32
Upside: +4,900.00%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $13.98
Upside: +329.18%
Jun 5, 2023
Reiterates: Buy
Price Target: $8
Current: $0.27
Upside: +2,846.59%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.55
Upside: +985.97%
Jun 1, 2023
Assumes: Buy
Price Target: $9
Current: $0.39
Upside: +2,207.69%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $2.64
Upside: -24.24%
May 25, 2023
Assumes: Buy
Price Target: $17
Current: $0.13
Upside: +13,328.12%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $3.96
Upside: +278.79%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $1.57
Upside: +536.94%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $2.92
Upside: +413.70%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $12.17
Upside: +803.86%
Mar 2, 2020
Initiates: Buy
Price Target: $80
Current: $0.72
Upside: +10,966.54%